Detection of Bourbon Virus-Specific Serum Neutralizing Antibodies in Human Serum in Missouri, USA

Gayan Bamunuarachchi(Washington University in St. Louis), Adrianus C. M. Boon, Ali H. Ellebedy(Washington University in St. Louis), Daved H. Fremont(Washington University in St. Louis), Sean P. J. Whelan(University of Pittsburgh Medical Center), Ya-Nan Dai(Washington University in St. Louis), Paul W. Rothlauf(Harvard University), David Wang(Washington University in St. Louis), Houda Harastani(Washington University in St. Louis)
mSphere
May 24, 2022
10.1128/msphere.00164-22
Cited by 19

Related Papers

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
|Science|2003|2.6k
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
|Cell|2015|1.3k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
|Nature|2021|882
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851